首页> 美国卫生研究院文献>Chinese Medical Journal >Intra-operative molecular diagnosis of sentinel lymph node and prediction of non-sentinel lymph node metastasis in breast cancer patients
【2h】

Intra-operative molecular diagnosis of sentinel lymph node and prediction of non-sentinel lymph node metastasis in breast cancer patients

机译:乳腺癌患者中淋巴结淋巴结的术术分子诊断及非哨兵淋巴结转移的预测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To the Editor: Sentinel lymph node biopsy has become a universal procedure performed in node-negative breast cancer patients. The accurate intra-operative assessment of the sentinel lymph node (SLN) is prominent in enabling axillary lymph node dissection (ALND) synchronously performed during the breast surgery, in case of the morbidity, inconvenience, and extra cost resulting from a second operation. One-step nucleic acid amplification (OSNA) assay (Sysmex, Kobe, Japan) is a moderately sensitive molecular technique combining node tissue homogenization and subsequent reverse-transcription loop-mediated isothermal amplification of cytokeratin-19 (CK-19) mRNA in a single reaction. The assay could accurately discern nodal metastases of over 0.2 mm intra-operatively.
机译:对于编辑:Sentinel淋巴结活检已成为在节点阴性乳腺癌患者中进行的普遍手术。在乳房手术期间在乳房手术期间使腋窝淋巴结(ALND)在使腋窝淋巴结剖析(ALND)在发病率,不便和第二次操作产生的费用的情况下,突出的腋窝淋巴结(SLN)突出。一步核酸扩增(OSNA)测定(Sysmex,Kobe,日本)是一种适度敏感的分子技术,将节点组织均质化和随后的逆转录环介导的细胞角蛋白-19(CK-19)mRNA的等温扩增单一反应。测定可以准确地识别可操作地辨别超过0.2mm的节点转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号